Mirae Asset Global ETFs Holdings
ANAB icon

Mirae Asset Global ETFs Holdings’s AnaptysBio ANAB Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Buy
11,639
+1,153
+11% +$69.9K ﹤0.01% 1762
2026
Q1 		$581K Sell
10,486
-155
-1% -$8.34K ﹤0.01% 1812
2025
Q4 		$515K Sell
10,641
-26
-0.2% -$1.01K ﹤0.01% 1880
2025
Q3 		$315K Buy
+10,667
New +$245K ﹤0.01% 2088
2025
Q2 		– Sell
-14,205
Closed -$265K – 3015
2025
Q1 		$265K Sell
14,205
-807
-5% -$13.5K ﹤0.01% 2178
2024
Q4 		$199K Buy
15,012
+2,701
+22% +$65.4K ﹤0.01% 2391
2024
Q3 		$410K Buy
12,311
+679
+6% +$23.2K ﹤0.01% 2016
2024
Q2 		$291K Buy
+11,632
New +$271K ﹤0.01% 2085

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ANAB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its AnaptysBio (ANAB) stake by 11% in Q2 2026, buying an estimated $69.9K and bringing the position to 11,639 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Mirae Asset Global ETFs Holdings first reported a position in ANAB in Q2 2024 and has held it in 8 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 11,639 shares of AnaptysBio worth $782K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 1,153 AnaptysBio shares in Q2 2026, an estimated $69.9K.
  • AnaptysBio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1762 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in AnaptysBio in Q2 2024 and has held it in 8 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.